218 related articles for article (PubMed ID: 21565605)
1. Psychiatric sequelae of Spice, K2, and synthetic cannabinoid receptor agonists.
Benford DM; Caplan JP
Psychosomatics; 2011; 52(3):295. PubMed ID: 21565605
[No Abstract] [Full Text] [Related]
2. Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong.
Tung CK; Chiang TP; Lam M
East Asian Arch Psychiatry; 2012 Mar; 22(1):31-3. PubMed ID: 22447803
[TBL] [Abstract][Full Text] [Related]
3. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
Every-Palmer S
Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced psychoses.
Hurlbut KM
Emerg Med Clin North Am; 1991 Feb; 9(1):31-52. PubMed ID: 2001668
[TBL] [Abstract][Full Text] [Related]
5. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
Besli GE; Ikiz MA; Yildirim S; Saltik S
J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
[TBL] [Abstract][Full Text] [Related]
6. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010.
Hoyte CO; Jacob J; Monte AA; Al-Jumaan M; Bronstein AC; Heard KJ
Ann Emerg Med; 2012 Oct; 60(4):435-8. PubMed ID: 22575211
[TBL] [Abstract][Full Text] [Related]
7. "Spice" girls: synthetic cannabinoid intoxication.
Schneir AB; Cullen J; Ly BT
J Emerg Med; 2011 Mar; 40(3):296-9. PubMed ID: 21167669
[TBL] [Abstract][Full Text] [Related]
8. Synthetic drugs: bath salts and spice.
Randolph SA
Workplace Health Saf; 2014 Feb; 62(2):88. PubMed ID: 24512723
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermia and severe rhabdomyolysis from synthetic cannabinoids.
Sweeney B; Talebi S; Toro D; Gonzalez K; Menoscal JP; Shaw R; Hassen GW
Am J Emerg Med; 2016 Jan; 34(1):121.e1-2. PubMed ID: 26143311
[TBL] [Abstract][Full Text] [Related]
10. Risky recreation: synthetic cannabinoids have dangerous effects.
McGuinness TM; Newell D
J Psychosoc Nurs Ment Health Serv; 2012 Aug; 50(8):16-8. PubMed ID: 22801822
[TBL] [Abstract][Full Text] [Related]
11. The rise in K2 use with varying clinical symptoms and the potential for ED crowding.
Roy AA; DeNonno L; Becerra I; Chirurgi R; McCorkell P; Hassen GW
Am J Emerg Med; 2015 Apr; 33(4):582. PubMed ID: 25662800
[No Abstract] [Full Text] [Related]
12. Could spice drugs induce psychosis with abnormal movements similar to catatonia?
Haro G; Ripoll C; Ibáñez M; Orengo T; Liaño VM; Meneu E; Hernández F; Traver F
Psychiatry; 2014; 77(2):206-8. PubMed ID: 24865202
[No Abstract] [Full Text] [Related]
13. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report.
Durand D; Delgado LL; de la Parra-Pellot DM; Nichols-Vinueza D
Clin Schizophr Relat Psychoses; 2015 Jan; 8(4):205-8. PubMed ID: 23518784
[TBL] [Abstract][Full Text] [Related]
14. Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces.
Loeffler G; Hurst D; Penn A; Yung K
Mil Med; 2012 Sep; 177(9):1041-8. PubMed ID: 23025133
[TBL] [Abstract][Full Text] [Related]
15. The social bases of drug-induced experiences.
Becker HS
NIDA Res Monogr; 1980 Mar; 30():180-90. PubMed ID: 6779177
[No Abstract] [Full Text] [Related]
16. [Drug dependence and psychoses. Psychotic syndromes in juvenile drug users].
Bron B
Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1982; 32():1-205. PubMed ID: 6984728
[No Abstract] [Full Text] [Related]
17. Adolescence and drug abuse: biomedical consequences.
Cohen S
NIDA Res Monogr; 1980; 38():104-12. PubMed ID: 6121291
[No Abstract] [Full Text] [Related]
18. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings.
Hermanns-Clausen M; Kneisel S; Szabo B; Auwärter V
Addiction; 2013 Mar; 108(3):534-44. PubMed ID: 22971158
[TBL] [Abstract][Full Text] [Related]
19. Geographic distribution of synthetic cannabinoid exposures reported to Texas poison centers.
Forrester MB; Haywood T
Am J Drug Alcohol Abuse; 2012 Nov; 38(6):603-8. PubMed ID: 22571605
[TBL] [Abstract][Full Text] [Related]
20. The "new" marijuana.
Wells DL; Ott CA
Ann Pharmacother; 2011 Mar; 45(3):414-7. PubMed ID: 21325097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]